The Committee discusses Geron Corporation’s New Drug Application (NDA) 217779 for Imetelstat for injection for the proposed indication for treatment of transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes on March 14 at 9:03 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GERN:
